Last Updated: September 28, 2026

BECONASE Drug Patent Profile

Name: BECONASE Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

✉ Email this page to a colleague

« Back to Dashboard

When do Beconase patents expire, and when can generic versions of Beconase launch?

Beconase is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in BECONASE is beclomethasone dipropionate monohydrate. There are two drug master file entries for this compound. Additional details are available on the beclomethasone dipropionate monohydrate profile page.

AI Deep Research

Questions you can ask:

What is the 5 year forecast for BECONASE?
What are the global sales for BECONASE?
What is Average Wholesale Price for BECONASE?

Summary for BECONASE

US Patents:	0
Applicants:	1
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	63
Clinical Trials:	4
Patent Applications:	5,578
Drug Prices:	Drug price information for BECONASE
What excipients (inactive ingredients) are in BECONASE?	BECONASE excipients list
DailyMed Link:	BECONASE at DailyMed

Drug patent expirations by year for BECONASE

Recent Clinical Trials for BECONASE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
West Penn Allegheny Health System	Phase 4
University Health Network, Toronto	N/A
Glaucoma Research Society of Canada	N/A

See all BECONASE clinical trials

US Patents and Regulatory Information for BECONASE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glaxosmithkline	BECONASE	beclomethasone dipropionate	AEROSOL, METERED;NASAL	018584-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Glaxosmithkline	BECONASE AQ	beclomethasone dipropionate monohydrate	SPRAY, METERED;NASAL	019389-001	Jul 27, 1987		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for BECONASE

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Glaxosmithkline	BECONASE	beclomethasone dipropionate	AEROSOL, METERED;NASAL	018584-001	Approved Prior to Jan 1, 1982	4,364,923	⤷ Start Trial
Glaxosmithkline	BECONASE	beclomethasone dipropionate	AEROSOL, METERED;NASAL	018584-001	Approved Prior to Jan 1, 1982	4,414,209	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for BECONASE

See the table below for patents covering BECONASE around the world.

Subscribe to access the full database, or Start Trial
Country	Patent Number	Title	Estimated Expiration
Argentina	196524	UN METODO PARA CONVERTIR UN ESTEROIDE A UNA FORMA QUE NO EXHIBE CRISTALINO EN PROPULSORES DE AEROSOL	⤷ Start Trial
Austria	348115		⤷ Start Trial
Austria	352973		⤷ Start Trial
Austria	A302275		⤷ Start Trial
Austria	A352973		⤷ Start Trial
Australia	471577		⤷ Start Trial
Australia	5466073		⤷ Start Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.